Tempus AI Inc. (TEM) was one of ARK’s more prominent biotech-related purchases. ARK added 61,114 shares through ARK Genomic ...
Strong demand for military equipment helped U.S. defense contractors report higher Q3 revenue and growing order books.
This week received a slew of commentary from Magnificent Seven (MAG 7) leaders with big tech earnings kicking off across the ...
U.S.-listed biotech buyers continued to favor asset deals over multi-billion-dollar company takeovers this week.
Pure-EV player Rivian delivered a clear third-quarter beat and raised its 2026 delivery outlook on the back of early R2 ...
U.S. stock indices ended lower on Friday, with the S&P 500 and Nasdaq also closing the month lower after investors moved out ...
The FDA granted accelerated approval to Inovio Pharmaceuticals’ (INO) Voceryq, a plasmid DNA-based immunotherapy for adults ...
Talks remain ongoing and a deal may not materialize, the report said, while adding that any transaction would likely include ...
Higher Rates Ahead? Three Fed Officials Have Called For A Gradual Uptick In Interest Rates This Week
Top Federal Reserve officials signaled this week that further interest rate increases will be required to control persistent ...
Amazon.com Inc. (AMZN) has arranged up to $80 billion in supplier financing credit line as it prepares for aggressive ...
Analysts turned bullish on Eli Lilly (LLY) on Friday, betting on its obesity-drug leadership and expanding pipeline.
Investors are now focused on the company’s projected third-quarter 2026 results, estimated for Monday, November 2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results